170513 ⎘
Assays involving biological materials from specific organisms or of a specific nature from animals; from humans; Assays involving receptors, cell surface antigens or cell surface determinants for hormones G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
Method and Kit for Rapid Measurement of Autoantibody Activity with Respect to TSH Receptor
#2AFFINITY ENCODED OSCILLATOR ARRAYS, METHODS, AND RELATED ASPECTS FOR MEASURING MOLECULAR BINDING KINETICS
#3METHODS OF IDENTIFYING COMPOUNDS THAT MODULATE LAUNDRY MALODOR, MOLDY MALODOR, OR SWEAT MALODOR
#4Taste Bud Cell Emulator Chip with Electrochemical Sensing, Cellular, and Neurological Processing
#5REDUCTION OF BITTER TASTE OF ACTIVE PHARMACEUTICAL INGREDIENTS AND RELATED ASSAYS AND SCREENING METHODS
#6NANOVESICLE COMPRISING HETERODIMERIC G-PROTEIN COUPLED RECEPTOR, METHOD FOR PREPARING NANOVESICLE, FIELD EFFECT TRANSISTOR-BASED TASTE SENSOR COMPRISING NANOVESICLE, AND METHOD FOR MANUFACTURING TASTE SENSOR
#7SYSTEM AND METHOD FOR BIOMOLECULE DETECTION
#8THERAPEUTIC ANTIBODIES
#9USE OF FSH-RECEPTOR LIGANDS FOR DIAGNOSIS AND THERAPY OF ATHEROSCLEROSIS
#10CELLS DERIVED FROM POLYPEDILUM VANDERPLANKI AND ODOR SENSOR EQUIPPED THEREWITH
#11Binding Domains Directed Against GPCR:G Protein Complexes and Uses Derived Thereof
#12G-PROTEIN COUPLED RECEPTOR ASSAY
#13RECOMBINANT THYROID-STIMULATING HORMONE RECEPTOR PROTEIN, PREPARATION METHOD AND APPLICATION THEREOF
#14COMPOSITIONS, SYSTEMS, AND METHODS FOR DETERMINATION OF T2R AND/OR T1R PHENOTYPE IN INDIVIDUALS TO PREDICT WINE TASTING PREFERENCES, CHARACTERIZATION OF WINE IN RELATION TO INDIVIDUAL TASTING PREFERENCES, AND SELECTION OF WINE
#15COMPOSITIONS AND METHODS FOR TREATING MELANOMA
#16SCREENING METHOD AND INDENDITIES OF BIOMARKERS FOR DIFFERENTIAL DIAGNOSIS OF PARKINSONISM AND/OR COGNITIVE IMPAIRMENT
#17NOVEL THERAPEUTIC AGENT THAT SUPPRESSES METASTASIS AND PROLIFERATION OF OSTEOSARCOMA AND GLIOMA
#18METHOD FOR THE QUANTIFICATION OF THE ACTIVATION STATE OF G-PROTEIN-COUPLED RECEPTORS IN A HUMAN BIOLOGICAL SAMPLE
#19DIAGNOSTIC METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER
#20METHOD FOR MEASURING RESPONSE OF OLFACTORY RECEPTOR TO SUBSTANCE
#21KIT AND METHOD FOR SCREENING OF ANTIBODY USING GPCR-EMBEDDED NANODISCS
#22USE OF ODORANT RECEPTOR FOR SUPPRESSING LACTATE-INDUCED M2-TYPE DIFFERENTIATION OF TUMOR-ASSOCIATED MACROPHAGES AND TUMOR GROWTH
#23Opsins as Chemosensory Receptors and Related Methods
#24BIOELECTRONIC SYSTEM FOR RARE CELL SEPARATION AND APPLICATION THEREOF
#25COMPOSITIONS AND METHODS FOR DETECTING AUTOANTIBODIES
#26SYSTEM AND METHOD FOR HOMOGENOUS GPCR PHOSPHORYLATION AND IDENTIFICATION OF BETA-2 ADRENERGIC RECEPTOR POSITIVE ALLOSTERIC MODULATORS
#27DIRECTED EVOLUTION OF MEMBRANE PROTEINS IN EUKARYOTIC CELLS WITH A CELL WALL
#28MUTANT G-PROTEIN COUPLED RECEPTORS AND METHODS FOR SELECTING THEM
#29KOKUMI TASTE ENHANCEMENT AND RELATED SCREENING METHODS
#30GPCR SCREENING METHOD TO IDENTIFY NON-HALLUCINOGENIC COMPOUNDS
#31DETECTION AND TREATMENT OF AUTISM SPECTRUM DISORDERS
#32VIRION OSCILLATOR MICROARRAYS, METHODS, AND RELATED ASPECTS FOR DETERMINING BINDING KINETICS OF LIGANDS
#33COMPOSITIONS AND METHODS FOR TREATING G PROTEIN COUPLED RECEPTOR MEDIATED CONDITIONS
#34BETA-ARRESTIN COMPOSITIONS AND ASSOCIATED METHODS
#35Method And System For Determining Intracellular Mediators' Activity
#36Probe and Method for Detecting Membrane-Associated Molecules in Living Cells
#37HIGH-SENSITIVITY DETECTION OF GPCR ACTIVITY AND USES THEREOF
#38ANTIBODIES THAT BIND HUMAN CANNABINOID 1 (CB1) RECEPTOR
#39Method for Measuring Modulation in the Activity of a G Protein-Coupled Receptor
#40BIOSENSOR FOR DETECTING SMELL, SCENT, AND TASTE
#41ANTI-G-PROTEIN ALPHA ANTIBODY
#42REAL-TIME G-PROTEIN COUPLED RECEPTOR (GPCR) LINKED BIOLUMINESCENT SENSING OF BIOLOGICAL TARGETS AND PROCESSES
#43NOVEL FLAVORS, FLAVOR MODIFIERS, TASTANTS, TASTE ENHANCERS, UMAMI OR SWEET TASTANTS, AND/OR ENHANCERS AND USE THEREOF
#44ASSAY FOR REAL-TIME SIMULTANEOUS RECRUITMENT OF ARRESTIN ISOFORMS TO G PROTEIN-COUPLED RECEPTORS
#45BIOASSAY METHOD
#46Screening Methods and Assays for Use with Transmembrane Proteins, in Particular with GPCRs
#47SYSTEMS AND METHODS FOR MEASURING CELL SIGNALING PROTEIN ACTIVITY
#48Novel Selective ACKR3 Modulators and Uses Thereof
#49BITTER TASTE RECEPTOR BLOCKERS AND METHODS OF THEIR IDENTIFICATION
#50Monoclonal Antibodies to ELTD1 and Uses Thereof
#51PREVENTION OR TREATMENT OF FIBROTIC DISEASE
#52PAR2 MODULATION AND METHODS THEREOF
#53SCREENING METHODS USING CANINE T2R RECEPTORS AND PET FOOD PRODUCTS AND COMPOSITIONS IDENTIFIED USING THE SAME
#54Protein binding domains stabilizing functional conformational states of GPCRS and uses thereof
#55METHOD FOR MEASURING THE MODULATION OF THE ACTIVATION OF A G PROTEIN-COUPLED RECEPTOR WITH GTP ANALOGUES
#56ECTOPIC OLFACTORY RECEPTORS AND USES THEREOF
#57COMPOSITIONS AND METHODS RELATED TO LATROPHILINS AS BIOMARKERS FOR HAEMATOPOIETIC CELL CANCER
#58METHOD FOR PREVENTING OR TREATING HEART FAILURE BY ADMINISTERING A MEDICAMENT CONTAINING AN ANTAGONIST OF CORTICOTROPIN RELEASING HORMONE RECEPTOR 2 (CRHR2)
#59Method and Kit for Rapid Measurement of Autoantibody Activity with Respect to TSH Receptor
#60System and Method to Detect Small Molecules
#61ARRDC1-MEDIATED MICROVESICLES (ARMMS) AND USES THEREOF
#62Wnt7 variants capable of activating g-protein coupled receptor (Gpr)124/Reck/frizzled/lipoprotein receptor-related protein (LRP)-mediated Wnt signaling
#63Biomarker composition for predicting cancer malignant prognosis induced by microplastic exposure
#64USE OF THE TAS1R3 PROTEIN AS A MARKER FOR THERAPEUTIC, DIAGNOSTIC, AND/OR PROGNOSTIC PURPOSES FOR TUMORS THAT EXPRESS SAID PROTEIN
#65METHODS OF DETERMINING INTERFERON HAVING DIRECT INHIBITORY EFFECTS ON TUMORS AND USES THEREOF
#66FRIZZLED5 PROTEIN-BINDING AGENTS
#67BIOSENSORS FOR DETECTING ARRESTIN SIGNALING
#68Compositions and methods for detecting and/or treating inflammation
#69Synthetic odorant receptors
#70Method for identifying malodour counteractants
#71G protein-coupled receptor (GPCR) ligand assay
#72METHODS FOR SCREENING FOR BINDING PARTNERS OF G-PROTEIN COUPLED RECEPTORS
#73Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatment
#74Antibodies against the human fshr extracellular domain
#75Method of treating and prognosing scoliotic patient subgroups
#76METHOD FOR PREDICTING THE RISK OF GETTING CANCER OR DIAGNOSING CANCER IN A FEMALE SUBJECT
#77G-PROTEIN-COUPLED RECEPTOR INTERNAL SENSORS
#78Methods of treating or preventing fibrosis in non-alcoholic fatty liver disease
#79Mutant G-protein coupled receptors and methods for selecting them
#80METHOD OF IDENTIFYING LAUNDRY MALODOR, MOLDY MALODOR AND/OR SWEAT MALODOR MODULATING COMPOUNDS
#81Method for identifying positive allosteric modulators for odorant receptors
#82GPCRs in cancer-associated fibroblasts
#83Compositions and methods for detecting autoantibodies
#84Cancer stem cell-specific molecule
#85Detection of analytes using live cells
#86Screening method for materials that suppress characteristic body odor of elderly people
#87Vitamin E-based amphipathic compound, and use thereof
#88SCREENING METHODS USING CANINE T2R RECEPTORS AND PET FOOD PRODUCTS AND COMPOSITIONS IDENTIFIED USING THE SAME
#89Nanovesicle comprising heterodimeric G-protein coupled receptor, method for preparing nanovesicle, field effect transistor-based taste sensor comprising nanovesicle, and method for manufacturing taste sensor
#90SYSTEMS AND METHODS FOR THE ASSESSMENT OF G-PROTEIN ACTIVATION
#91Detection of membrane proteins
#92Binding domains directed against GPCR:G protein complexes and uses derived thereof
#93Compositions comprising G protein-coupled receptors maintained in a conformationally selective manner by a modulator
#94SENSITIVE DETECTION OF G-PROTEIN COUPLED RECEPTOR-ASSOCIATED SORTING PROTEIN 1 (GASP-1), GASP-1 MICROVESICLES, AND GASP-1 EXOSOMES
#95Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
#96Method for treating a chronic itch condition by administering small molecule MrgprX4 antagonists
#97ANTIFUGETACTIC AGENTS FOR THE TREATMENT OF CANCERS
#98Optogenetic probes for measuring membrane potential
#99Methods and systems for detecting an analyte or classifying a sample
#100Chemical sensor and method for detecting target substance
#101Specific GNAI:GIV interaction screening assays, methods and compositions
#102T1R HETERO-OLIGOMERIC TASTE RECEPTORS, CELL LINES THAT EXPRESS SAID RECEPTORS, AND TASTE COMPOUNDS
#103Method of identifying musk compounds
#104Protein binding domains stabilizing functional conformational states of GPCRS and uses thereof
#105A CELL-BASED ASSAY AND KITS FOR ASSESSING SERUM ANTICHOLINERGIC ACTIVITY
#106Human follicle-stimulating hormone receptor (FSHR) extracellular domain antibodies and methods of use thereof
#107Compositions and methods for detecting and/or treating inflammation
#108Biosensor for detecting smell, scent, and taste
#109PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF
#110Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof
#111PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF
#112PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF
#113METHODS AND COMPOSITIONS FOR TREATING SOLID TUMORS AND ENHANCING TUMOR VACCINES
#114Methods for increasing palatability of pet foodstuff
#115Fluorescent fusion polypeptide capable of detecting phosphorylation of cellular membrane receptors by GRKs (G-protein receptor kinases) and/or receptor tyrosine kinases (RTKs)
#116Opioid receptor binding agents and uses thereof
#117Membrane span-kinase fusion protein and the uses thereof
#118Method of Identifying Transmembrane Protein-interacting Compounds
#119Ectopic olfactory receptors and uses thereof
#120GPCR (GPR113) INVOLVED IN FAT, FATTY ACID AND/OR LIPID-ASSOCIATED TASTE AND USE IN ASSAYS FOR IDENTIFYING TASTE MODULATORY
#121IMMUNE MODULATORS FOR REDUCING IMMUNE-RESISTANCE IN MELANOMA AND OTHER PROLIFERATIVE DISEASES
#122MUTANT G-PROTEIN COUPLED RECEPTORS AND METHODS FOR SELECTING THEM
#123System and method for homogenous GPCR phosphorylation and identification of beta-2 adrenergic receptor positive allosteric modulators
#124Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatment
#125TREATMENT OF INFLAMMATORY BOWEL DISEASE
#126Methods of using T1R hetero-oligomeric taste receptors to screen for compounds which modulate sweet or umami taste signaling
#127Screening methods using olfactory receptors and novel compounds identified using the same
#128Methods for increasing palatability of pet foodstuff
#129MARKER FOR THE CLASSIFICATION, DIAGNOSIS AND TREATMENT OF SCOLIOSIS
#130Methods for identifying modulators of GPR92
#131DIAGNOSTIC METHOD FOR PEDIATRIC ACUTE-ONSET NEUROPSYCHIATRIC SYNDROME (PANS) AND PEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC DISORDER ASSOCIATED WITH STREPTOCOCCI INFECTION (PANDAS)
#132Method for preventing or treating heart failure by administering a medicament containing an antagonist of corticotropin releasing hormone receptor 2 (CRHR2)
#133METHODS FOR SCREENING FOR BINDING PARTNERS OF G-PROTEIN COUPLED RECEPTORS
#134In vitro methods of detecting heteroligomeric T1R2/T2R3-expressing cells that are potentially sensitive to sweet tastants
#135MUTANT SMOOTHENED AND METHODS OF USING THE SAME
#136Method of making an aromagraph comprising ectopic olfactory receptors
#137Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof
#138PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF
#139Frizzled5 protein-binding agents
#140Therapeutic and diagnostic methods for autism spectrum disorders and other conditions
#141SCREENING METHODS USING CANINE T2R RECEPTORS AND PET FOOD PRODUCTS AND COMPOSITIONS IDENTIFIED USING THE SAME
#142Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
#143Stabilized liquid formulations containing receptors
#144Anti-human ADRB3 monoclonal antibody and application thereof in disease diagnosis and treatment
#145Systems and methods for determining cyclic nucleotide concentration and related pathway activation
#146METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMAS
#147Transformed cell lines expressing non-endogenous cell-surface selective guanosine-responsive G-protein coupled receptors
#148FOOD INTAKE, BODY WEIGHT AND GLUCOSE METABOLISM REGULATION BY MODULATION OF P2Y6 RECEPTOR SIGNALING
#149Diagnosis of a neuroautoimmune disease
#150Method for evaluating activity of G protein-coupled receptor (GPCR)
#151Method for identifying a compound useful in mitigating and/or the treatment of a disease associated with abnormal astrocytic function
#152Antibodies that bind human cannabinoid 1 (CB1) receptor
#153Method of Identifying Transmembrane Protein-interacting Compounds
#154CB2 RECEPTOR INTERNALIZATION
#155METHOD OF TREATING AND PROGNOSING SCOLIOTIC PATIENT SUBGROUPS
#156MU OPIOID RECEPTOR AGONIST ANALOGS OF THE ENDOMORPHINS
#157Compositions and methods for detecting and/or treating inflammation
#158Compositions and methods for diagnosing and treating endometriosis-related infertility
#159ANTIFUGETACTIC AGENTS FOR THE TREATMENT OF CANCERS
#160Cancer Diagnostic
#161G-protein coupled receptor (GPCR)-based biosensors and uses thereof
#162Methods of determining interferon having direct inhibitory effects on tumors and uses thereof
#163Antifugetactic agents for the treatment of cancers
#164Diagnosis of chronic fatigue diseases using detection antibodies directed against a β-adrenergic receptor
#165Methods of treating pancreatic cancer using GPCR antagonists
#166METHOD FOR IDENTIFYING COMPOUNDS THAT MODULATE A T2R TASTE RECEPTOR
#167Proximity based methods for selection of binding partners
#168Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof
#169ANTI-FUGETACTIC AGENTS FOR THE TREATMENT OF CANCERS
#170ANTIFUGETACTIC AGENTS FOR THE TREATMENT OF CANCERS
#171ANTIFUGETACTIC AGENTS FOR THE TREATMENT OF CANCERS
#172ANTIFUGETACTIC AGENTS FOR THE TREATMENT OF CANCERS
#173Complexes comprising transmembrane receptors and antibodies that bind the receptors in a conformationally selective manner
#174T2R taste receptors and genes encoding same
#175T1R taste receptors and genes encoding same
#176MUTANT G-PROTEIN COUPLED RECEPTORS AND METHODS FOR SELECTING THEM
#177Bioactive peptides having insecticide activity
#178TREATMENT OF DIABETES USING AGONISTS OF THE MAS-RELATED GPCR D
#179Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof
#180METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF PANCREATIC CANCER
#181ARRDC1-mediated microvesicles (ARMMS) and uses thereof
#182Methods of using chimeric receptors to identify autoimmune disease
#183Diagnostic method for pediatric acute-onset neuropsychiatric syndrome (PANS) and pediatric autoimmune neuropsychiatric disorder associated with streptococci infection (PANDAS)
#184STRAIN OF LACTOBACILLUS ACIDOPHILUS HAVING ANALGESIC PROPERTIES IN THE GASTROINTESTINAL SYSTEM
#185Optogenetic probes for measuring membrane potential
#186DIRECTED EVOLUTION OF MEMBRANE PROTEINS IN EUKARYOTIC CELLS WITH A CELL WALL
#187T1R hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds
#188POSITIVE ALLOSTERIC MODULATORS OF THE DELTA-OPIOID RECEPTOR
#189Diagnostics and Therapeutics for Diseases Associated With G-Protein Coupled Receptor AdipoR2 (AdipoR2)
#190Methods of detecting T1R hetero-oligomeric taste receptor expression to identify cells that are potentially sensitive to sweet tastants
#191Mu opioid receptor agonist analogs of the endomorphins
#192Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assays
#193Method of Identifying Transmembrane Protein-interacting Compounds
#194Detection of analytes using live cells
#195EXPRESSION AND FUNCTION OF GPR64/ADGRG2 IN ENDOCRINE SYSTEMS AND METHODS TO TARGET IT THERAPEUTICALLY
#196DIAGNOSIS OF AN AUTOIMMUNE DISEASE USING DETECTION OF ANTIBODIES DIRECTED AGAINST C5A-RECEPTOR
#197ANTIFUGETACTIC AGENTS FOR THE TREATMENT OF CANCERS
#198Diagnostic of Obliterative Arteriopathies
#199Detection of an immune response
#200Optogenetic probes for measuring membrane potential
#201Biomimetic chemical sensors using nanoelectronic readout of olfactory receptors
#202Human G protein alpha subunit gail with at least one mutated amino acid residue
#203Methods for identifying a receptor for a ligand and uses thereof
#204Feline bitter taste receptors and methods
#205Binding domains directed against GPCR:G protein complexes and uses derived thereof
#206Method for predicting autism spectrum disorders by cannabinoid and cannabinoid receptor expression
#207Biosensor for detecting smell, scent, and taste
#208Biosensor based on Gβγ-interacting proteins to monitor G-protein activation
#209FRIZZLED-BINDING AGENTS AND USES THEREOF
#210Methods of using TIR hetero-oligomeric receptors for screening compounds that modulate sweet or umami taste
#211KIT FOR FORMULATION OF LIPOSOMAL DOXORUBICIN MODIFIED WITH BIOACTIVE PEPTIDES FOR SELECTIVE TARGETING OF RECEPTORS OVEREXPRESSED BY CANCER CELLS
#212G protein coupled receptor 85 and SREB3 knockout mice and uses thereof
#213Opioid receptor binding agents and uses thereof
#214METHODS OF TREATING MELANOMA
#215Method for diagnosing G-protein coupled receptor-related diseases
#216Radiolabeled cannabinoid receptor 2 ligand
#217Protein binding domains stabilizing functional conformational states of GPCRS and uses thereof
#218Use of compounds inhibiting apelin / APJ / GP130 signaling for treating cancer
#219METHODS AND COMPOSITIONS FOR ASSESSING PREDICTING RESPONSIVENESS TO A TNF INHIBITOR
#220CELL LINE, SYSTEM AND METHOD FOR OPTICAL CONTROL OF SECONDARY MESSENGERS
#221NOVEL CELL LINES AND METHODS
#222Systems and methods for the monitoring of protein complex formation in cells
#223Methods and compositions for treating solid tumors and enhancing tumor vaccines
#224IDENTIFICATION OF CXCR8, A NOVEL CHEMOKINE RECEPTOR
#225Virion display array for profiling functions and interactions of human membrane proteins
#226G-protein coupled receptor-associated diagnostics and therapeutics for B-cell chronic lymphocytic leukemia
#227Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof
#228METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMAS
#229Therapeutic and diagnostic methods for autism spectrum disorders and other conditions
#230Methods for screening for binding partners of G-protein coupled receptors
#231High-affinity small molecule formylpeptide receptor ligands from screening of combinatorial mixture-based libraries
#232Mutant smoothened and methods of using the same
#233G PROTEIN COUPLED RECEPTORS AND USES THEREOF
#234Compositions and methods for detecting and/or treating inflammation
#235Bioactive peptides having insecticide activity
#236COMPOSITIONS FOR CLASSIFYING A HUMAN PEDIATRIC SUBJECT HAVING ADOLESCENT IDIOPATHIC SCOLIOSIS (AIS)
#237Mini-gastrin analogue, in particular for use in CCK2 receptor positive tumour diagnosis and/or treatment
#238Nanovesicle comprising heterodimeric G-protein coupled receptor, method for preparing nanovesicle, field effect transistor-based taste sensor comprising nanovesicle, and method for manufacturing taste sensor
#239Cancer marker and therapeutic target
#240Kits for classifying a subject having or at risk for developing idiopathic scoliosis
#241Methods for increasing palatability of pet foodstuff
#242Methods and means for treatment of osteoarthritis
#243Feline bitter taste receptors and methods
#244Marker for detecting proliferation and treatment capacities of adipose-derived stem cell cultured in medium containing EGF or BFGF, and use thereof
#245In vitro method using hetero-oligomeric T1R1/T1R3 taste receptors to identify umami tastants
#246Methods of Diagnosis and Treatment for Pulmonary Arterial Hypertension
#247Diagnostic method for pediatric acute-onset neuropsychiatric syndrome (PANS) and pediatric autoimmune neuropsychiatric disorder associated with streptococci infection (PANDAS)
#248Cancer stem cell-specific molecule
#249Electrified compositions for determining the risk of developing adolescent idiopathic scoliosis through the use of GI protein receptor
#250Method for determining mutateable ligand-GPCR binding at single amino acid resolution and pairs of mutated ligand and GPCR
#251Opioid detection based on high quality graphene transistor arrays and a synthetic mu receptor
#252G-protein coupled receptor (GPCR)-based biosensors and uses thereof
#253REAGENT INCLUDING ANTI-LGR6 ANTIBODIES FOR DETECTION AND DIAGNOSIS OF CANCER
#254Detection of an immune response
#255Methods of using U2-OS cells to identify potential sweet taste modulators
#256Method for searching for malodor control agent, malodor control agent, and malodor control method
#257Stabilized liquid formulations containing receptors
#258Methods of Identifying Candidate Compounds of the Human G Protein-Coupled Receptor, GPR50, as Modulators of Body Mass or Adiposity
#259T2R taste receptors and genes encoding same
#260Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assays
#261G Protein Coupled Receptor Libraries
#262METHOD OF TREATMENT OR PROPHYLAXIS INFTAMMATORY PAIN
#263Methods and compositions for treating and identifying compounds to treat age-related macular degeneration treatment
#264Method to increase bioavailability of the delta-opioid receptor for management of pain and neuropsychiatric disorders
#265Feline bitter taste receptors and methods
#266Chimeric polypeptides comprising G protein-coupled receptors and VHH antibodies
#267Method for predicting autism spectrum disorders by cannabinoid and cannabinoid receptor expression
#268Optogenetic probes for measuring membrane potential
#269PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING STRESS URINARY INCONTINENCE OR MIXED URINARY INCONTINENCE, AND METHOD FOR SCREENING COMPOUND COMPRISED IN SAID PHARMACEUTICAL COMPOSITION
#270TRH binding site in human CNS
#271Method for selecting agents that bind to transmembrane receptors in a conformationally selective manner
#272Method of screening compounds for the treatment of diabetes
#273Positive allosteric modulators and silent allosteric modulators of the Mu opioid receptor
#274PEPTIDIC AND NON PEPTIDIC LIGANDS FOR IMMUNODETECTION OF THE RECEPTOR FOR UROTENSIN II
#275Methods for identifying compounds that inhibit G protein-coupled receptor (GPR84) agonist-stimulated chemotaxis
#276T1R taste receptors and genes encoding same
#277MU OPIOID RECEPTOR AGONIST ANALOGS OF THE ENDOMORPHINS
#278Methods for detecting allosteric modulators of protein
#279Methods of using chimeric receptors to identify autoimmune disease
#280Luciferase biosensors for cAMP
#281Optogenetic probes for measuring membrane potential
#282METHOD AND DEVICE FOR DETECTING ILLEGAL DRUGS
#283Method for identifying compounds that modulate a T2R taste receptor
#284Cell based sensor
#285Somatostatin analogs and dimers thereof
#286INHIBITORS OF CENTRAL NERVOUS SYSTEM VASOACTIVE INHIBITORY PEPTIDE RECEPTOR 2
#287Cell line, system and method for optical control of secondary messengers
#288TRANSGENIC NON-HUMAN ANIMAL AND USES THEREOF
#289MICROARRAYS OF G PROTEIN COUPLED RECEPTORS
#290Compositions and methods for treating hypertension
#291Differentiation marker and differentiation control of eye cell
#292Screening Assay for Insecticides
#293GPCR with improved cell surface expression
#294ASSAY SYSTEM FOR GLP-2 RECEPTOR LIGANDS
#295Methods for detecting allosteric modulators of protein
#296METHODS FOR THE TREATMENT, THE PROGNOSTIC ASSESSMENT AND THE STAGING OF NON-SMALL CELL LUNG CANCER
#297Substituted pyrazoloquinazolinones and pyrroloquinazolinones as allosteric modulators of group II metabotropic glutamate receptors
#298Methods and systems for detecting an analyte or classifying a sample
#299Method and device for the determination of platelet function under flow conditions
#300Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof